The overproduced eATP exerts its oncogenic effect in three ways: (1) Increased eATP can be hydrolyzed to eAdo by elevated expression of CD39 and CD73 on the surface of UQCRC1-overexpressing cancer cells. This evidence concerns the gene UQCRC1 and cancer.